Shots:
- The US FDA has granted 510(k) clearance to CARA System for non-invasive, patient-specific 3D visualization of the cardiac conduction system, with commercialization to begin in the coming mos.
- The CARA System combines the CARA MetisTM Simulator, a preprocedural CTA-based simulator to create a personalized 3D map of the cardiac conduction system, with the CARA AtlasTM Navigator, an intraprocedural navigator, which overlays this model onto live fluoroscopy to guide image-based cardiac interventions
- The system is designed to support preplanning & guidance of procedures near the cardiac conduction system, incl. TAVR & other percutaneous or surgical interventions, as well as therapies targeting the conduction system, such as conduction system pacing
Ref: PRnewswire |  Image: Cara Medical |  Press Release
Related News: VB Spine to Acquire Exclusive Rights to xvision Spine System from Augmedics
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
